Ephedrine Sulfate Injection
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Ephedrine Sulfate Injection is a sterile solution of Ephedrine Sulfate in Water for Injection. It contains NLT 95.0% and NMT 105.0% of the labeled amount of ephedrine sulfate [(C10H15NO)2 · H2SO4].
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
Sample: Mix 1 mL of Injection with 5 mL of alcohol, and evaporate on a steam bath with the aid of a current of air to dryness.
Acceptance criteria: The residue obtained from the Sample meets the requirements.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Solution A: To 1 L of water add 4 mL of triethylamine. Adjust with phosphoric acid to a pH of 4.0.
Mobile phase: Acetonitrile and Solution A (1:99)
System suitability solution: 0.1 mg/mL of USP Ephedrine Sulfate RS and 0.01 mg/mL of USP Pseudoephedrine Sulfate RS in water
Standard solution: 0.1 mg/mL of USP Ephedrine Sulfate RS in water
Sample solution: Nominally 0.1 mg/mL of ephedrine sulfate in water prepared as follows. Transfer a portion of Injection to a suitable volumetric flask. Dilute with water to volume, and mix well.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 206 nm
Column: 2.1-mm × 10-cm; 2.6-μm packing L11
Column temperature: 30°
Flow rate: 0.6 mL/min
Injection volume: 10 μL
Run time: NLT 3 times the retention time of ephedrine
System suitability
Samples: System suitability solution and Standard solution
Suitability requirements
Resolution: NLT 2.0 between ephedrine and pseudoephedrine, System suitability solution
Tailing factor: NMT 2.0, Standard solution
Relative standard deviation: NMT 0.73%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of ephedrine sulfate [(C10H15NO)2 · H2SO4] in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × 100
rU= peak response of ephedrine from the Sample solution
rS = peak response of ephedrine from the Standard solution
CS = concentration of USP Ephedrine Sulfate RS in the Standard solution (mg/mL)
CU = nominal concentration of ephedrine sulfate in the Sample solution (mg/mL)
Acceptance criteria: 95.0%–105.0%
4 IMPURITIES
Organic Impurities
Mobile phase, System suitability solution, and Chromatographic system: Proceed as directed in the Assay.
Standard solution: 1.0 μg/mL of USP Ephedrine Sulfate RS in water
Sample solution: Nominally 500 μg/mL of ephedrine sulfate in water prepared as follows. Transfer a portion of Injection to a suitable volumetric flask. Dilute with water to volume, and mix well.
System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 1 for the relative retention times.]
Suitability requirements
Resolution: NLT 2.0 between ephedrine and pseudoephedrine, System suitability solution
Relative standard deviation: NMT 2.0% for ephedrine, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of any individual impurity in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each impurity from the Sample solution
rS = peak response of ephedrine from the Standard solution
CS = concentration of USP Ephedrine Sulfate RS in the Standard solution (μg/mL)
CU = nominal concentration of ephedrine in the Sample solution (μg/mL)
Acceptance criteria: See Table 1. Disregard any peak less than 0.05%.
Table 1
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Ephedrine | 1.0 | - |
| Pseudoephedrinea | 1.2 | - |
| Any individual impurity | - | 0.2 |
| Total impurities | - | 2.0 |
a Process impurity included in the table for identification only. Process impurities are controlled in the drug substance, and are not to be reported or included in the total impurities of the drug product.
5 SPECIFIC TESTS
pH 〈791〉: 4.5–7.0
Other Requirements: Meets the requirements in Injections and Implanted Drug Products 〈1〉
Bacterial Endotoxins Test 〈85〉: NMT 1.7 USP Endotoxin Units/mg of ephedrine sulfate
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose or multiple-dose, light-resistant containers, preferably of Type I glass. Store at controlled room temperature.
USP Reference Standards 〈11〉
USP Ephedrine Sulfate RS
USP Pseudoephedrine Sulfate RS (C10H15NO)2 · H2SO4 428.54

